Skip to main content

Eli Lilly CEO to Trump: We're not jacking up our drug costs for profit

Eli Lilly's growth is not fueled much by increasing drug costs, says CEO David Ricks, who attended President Trump's Big Pharma meeting.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.